Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 56

The DOI matches its Crossref record.

The Added Value of 18F-FDG PET/CT for Evaluation of Patients with Esthesioneuroblastoma

Broski, Stephen M., Hunt, Christopher H., Johnson, Geoffrey B., Subramaniam, Ratham M., Peller, Patrick J.·2012·Journal of Nuclear Medicine
DOI 10.2967/jnumed.112.102897
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2967/jnumed.112.102897

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 22

  1. Broich, 1997, Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924, Anticancer Res., 17, 2683
  2. 10.1016/S1470-2045(01)00558-7 · doi:10.1016/s1470-2045(01)00558-7
  3. 10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L · doi:10.1002/1097-0142(197603)37:3<1571::aid-cncr2820370347>3.0.co;2-l
  4. 10.1001/archotol.133.3.276 · doi:10.1001/archotol.133.3.276
  5. 10.1007/s00405-010-1360-6 · doi:10.1007/s00405-010-1360-6
  6. Morita A Ebersold MJ Olsen KD Foote RL Lewis JE Quast LM . Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32:706–714. · doi:10.1097/00006123-199305000-00002
  7. 10.1001/archotol.129.11.1186 · doi:10.1001/archotol.129.11.1186
  8. 10.3174/ajnr.A2401 · doi:10.3174/ajnr.a2401
  9. Pickuth, 1999, Imaging of recurrent esthesioneuroblastoma, Br J Radiol., 72, 1052, 10.1259/bjr.72.863.10700820 · doi:10.1259/bjr.72.863.10700820
  10. 10.1007/s00234-009-0581-0 · doi:10.1007/s00234-009-0581-0
  11. 10.3174/ajnr.A1114 · doi:10.3174/ajnr.a1114
  12. 10.1097/01.rlu.0000200735.55296.73 · doi:10.1097/01.rlu.0000200735.55296.73
  13. Som, 2000, Imaging-based nodal classification for evaluation of neck metastatic adenopathy, AJR., 174, 837, 10.2214/ajr.174.3.1740837 · doi:10.2214/ajr.174.3.1740837
  14. 10.1097/00020840-200304000-00009 · doi:10.1097/00020840-200304000-00009
  15. 10.1001/archotol.132.2.134 · doi:10.1001/archotol.132.2.134
  16. 10.1001/archoto.2009.143 · doi:10.1001/archoto.2009.143
  17. Henze, 2005, Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas, J Nucl Med., 46, 763
  18. Henze, 2001, PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas, J Nucl Med., 42, 1053
  19. 10.1002/hed.20356 · doi:10.1002/hed.20356
  20. 10.1007/s00259-008-0874-2 · DOI · Paper page
  21. Krause, 2007, Nuklearmedizin., 46, 291, 10.3413/nukmed-282 · DOI
  22. 10.2967/jnumed.107.047787 · DOI · Paper page

Cited by

Metadata

Authors
Broski, S. M., Hunt, C. H., Johnson, G. B., Subramaniam, R. M., & Peller, P. J.
Venue
Journal of Nuclear Medicine
Publisher
Society of Nuclear Medicine
Published
2012-06-22
Volume
53
Issue
8
Pages
1200-1206
ISSN
  • 0161-5505
  • 2159-662X
DOI
10.2967/jnumed.112.102897
Cited by
56
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.